Skip to main content
    C

    Cybin Inc (CYBN)

    Official site

    BIOTECHNOLOGY

    $8.28
    +0.10 (+1.22%)

    Last updated: Jan 02, 2026 at 4:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    35%(7/20)
    Avg Surprise
    -983.62%
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 13
    		$-1.39$-1.33-4.61%Miss+51.4%
    Jun 25
    Reported Jul 1
    		$-1.46$-0.02-5787.10%Miss-7200.0%
    Mar 25
    Reported Mar 31
    		$-1.46$-1.23-18.70%Miss-4351.2%
    Dec 24
    Reported Feb 11
    		$-0.53$-0.03-1915.21%Miss-488.9%
    Sep 24
    Reported Nov 13
    		$-2.86$-0.02-11432.26%Miss-5620.0%
    Jun 24
    Reported Aug 8
    		$-0.02$-0.02+0.00%Beat+71.4%
    Mar 24
    Reported Jun 25
    		$-0.03$-0.03-9.33%Miss+53.1%
    Dec 23
    Reported Feb 14
    		$-0.09$-0.04-125.00%Miss-50.0%
    Sep 23
    Reported Nov 13
    		$-0.05$-0.05+0.00%Beat+16.7%
    Jun 23
    Reported Aug 14
    		$-0.07$-0.06-16.67%Miss+0.0%
    Mar 23
    Reported Jun 27
    		$-0.07$-0.06-16.67%Miss+30.0%
    Dec 22
    Reported Feb 16
    		$-0.06$-0.06+0.00%Beat+40.0%
    Sep 22
    Reported Nov 14
    		$-0.06$-0.07+14.29%Beat+45.5%
    Jun 22
    Reported Aug 8
    		$-0.07$-0.09+22.22%Beat+22.2%
    Mar 22
    Reported Jun 22
    		$-0.10$-0.10+0.00%Beat-25.0%
    Dec 21
    Reported Feb 10
    		$-0.10$-0.10+0.00%Beat+0.0%
    Sep 21
    Reported Nov 15
    		$-0.11$-0.10-10.00%Miss-
    Jun 21
    Reported Aug 13
    		$-0.09$-0.05-80.00%Miss-
    Mar 21
    Reported Jun 28
    		$-0.08$-0.05-60.00%Miss-
    Dec 20
    Reported Feb 16
    		$-0.10$-0.03-233.33%Miss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.92
    SMA 20$7.09
    SMA 50$6.56
    SMA 200N/A
    EMA 10$7.93
    EMA 20$7.39
    EMA 50$6.82
    EMA 200$6.95

    MACD

    Line: 0.61Signal: 0.46Hist: 0.15

    ADX

    ADX: 32.2+DI: 34.3-DI: 14.6

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down16.0
    PSAR$7.85

    Bollinger Bands

    Upper Band$9.09
    Lower Band$5.09
    %B Position5643%(Upper)
    Band Width0.80

    RSI (14-Day)

    Neutral
    69.1

    Momentum Oscillators

    Stoch %K74.7
    Stoch %D84.2
    Williams %R-30.3
    ROC (10d)21.9%
    Momentum1.49
    CCI (20d)98.4
    MFI (14d)88.7

    Volatility Measures

    ATR (14d)$0.47(5.7%)
    StdDev (20d)1.00
    Hist Vol56.3%(High)

    Volume Flow

    VWAP$8.27
    OBV3.0M
    AD Line-9.6M
    CMF (20d)0.272

    Volume Metrics

    Avg Vol (20d)918.0K
    Vol Ratio0.8x
    VWMA (20d)$7.38

    Pivot Points

    R3$8.99
    R2$8.69
    R1$8.44
    Pivot Point$8.14
    S1$7.89
    S2$7.59
    S3$7.34

    Advanced Oscillators

    TSI40.08
    Ultimate Osc64.8
    KST273.50

    Financial Data

    QuarterDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of RevenueN/AN/AN/AN/AN/AN/A$138,000$142,000$142,000$71,000$69,000$68,000
    Gross ProfitN/AN/AN/AN/AN/AN/A$-138,000$-142,000$-142,000$-71,000$-69,000$-68,000
    Operating Expenses$41.21M$28.89M$24.62M$33.27M$31.30M$58.25M$20.32M$25.20M$26.88M$13.91M$13.39M$13.70M
    R&D$23.86M$18.85M$14.99M$18.97M$19.72M$9.44M$8.04M$11.84M$7.44M$6.98M$6.59M$8.09M
    SG&A$17.35M$9.70M$9.63M$14.30M$11.49M$48.77M$12.24M$11.51M$19.36M$6.91M$6.11M$5.60M
    Operating Income$-41,210,000$-28,894,000$-24,624,000$-33,272,000$-31,304,000$-58,254,000$-20,317,000$-25,199,000$-27,024,000$-15,878,000$-13,611,000$-13,538,000
    Interest Income$1.50M$1.06M$955,000$1.44M$1.63M$3.08M$2.14M$342,000$141,000$52,000$84,000$148,000
    Interest Expense$1.46M$4.83M$0$0$0$0$0$0$3.31M$0$124,000$182,000
    Income Before Tax$-42,668,000$-33,722,000$-24,613,000$-30,579,000$-10,542,000$-57,192,000$-14,824,000$-21,346,000$-30,330,000$-11,890,000$-14,514,000$-13,720,000
    Income Tax Expense$0$0$0$0$0$0$0$-3,849,000$181,586$-2,020,000$-680,000$17,000
    Net Income$-42,668,000$-33,722,000$-24,613,000$-30,579,000$-10,542,000$-57,192,000$-14,824,000$-21,346,000$-30,330,000$-11,890,000$-12,375,000$-13,720,000
    EBITDAN/A$-28,865,000$-24,586,000N/A$-31,172,000$-58,111,000$-20,179,000$-25,053,000$-26,882,000$-13,839,000$-12,638,000$-13,635,000
    EBITN/A$-28,894,000$-24,624,000N/A$-31,304,000$-58,254,000$-20,317,000$-25,195,000$-27,024,000$-13,910,000$-12,707,000$-13,703,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CYBN

    News

    No news available

    Company news will appear here when available

    CYBN Competitors

    CompanyTicker
    Exagen IncXGN
    Niagen Bioscience, Inc.NAGE
    Pro-Dex IncPDEX
    Akebia TherAKBA
    Cartesian Therapeutics Inc.RNAC
    Eledon Pharmaceuticals IncELDN
    ProQR Therapeutics BVPRQR
    Entrada Therapeutics IncTRDA

    Sector: Healthcare

    CYBN Bull Case vs Bear Case

    Bear case

    • CYBN beat EPS estimates in 0.0% of its last 8 reported quarters.

    CYBN Earnings: Beat Rate and Next Report

    Beat rate
    0 of 8 quarters (0.0%)
    Average surprise
    -1122.8%

    Frequently Asked Questions About CYBN

    Does CYBN pay dividends?

    Cybin Inc (CYBN) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In